Following the discovery of the FBN2 gene mutation, the diagnosis of CCA has been reported with increased frequency, although true prevalence remains unknown [1]. Despite advancements in genetic testing, CCA can still be challenging to diagnose. Here, FBN2 is linked to congenital contractural arachnodactyly.